Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Cytotherapy. 2013 Nov 13;16(6):713–733. doi: 10.1016/j.jcyt.2013.10.002

Figure 2.

Figure 2

a schematic of transgenic α and β T cell receptors (αβT CRs) and chimeric antigen receptor (CARs) and shows the differences and similarities between these two most common strategies used to redirect the immune T cell response.